HSU Outcome | Odds Ratio (95% CI) P-Value | |
---|---|---|
Unadjusted Odds Ratio | Adjusted Odds Ratio* | |
Psychotropic Polypharmacy | Â | Â |
 All-cause ED visits | 1.27 (0.67–2.40) 0.472 | 1.04 (0.52–2.07) 0.913 |
 All-cause hospitalization | 1.67 (0.88–3.17) 0.114 | 1.38 (0.70–2.73) 0.357 |
 ED visits for pneumonia | 2.31 (1.00–5.31) 0.049** | 1.63 (0.65–4.08) 0.301 |
 Hospitalization for pneumonia | 2.37 (1.03–5.46) 0.043** | 1.74 (0.69–4.38) 0.239 |
 Mortality | 1.74 (0.85–3.53) 0.128 | 1.37 (0.63–2.99) 0.431 |
Antihypertensive Polypharmacy | Â | Â |
 All-cause ED visits | 0.88 (0.58–1.31) 0.518 | 0.86 (0.56–1.33) 0.495 |
 All-cause hospitalization | 0.80 (0.53–1.21) 0.287 | 0.79 (0.51–1.23) 0.293 |
 ED visits for pneumonia | 0.70 (0.38–1.30) 0.258 | 0.72 (0.37–1.42) 0.342 |
 Hospitalization for pneumonia | 0.75 (0.40–1.41) 0.369 | 0.78 (0.39–1.55) 0.474 |
 Mortality | 0.71 (0.44–1.14) 0.156 | 0.82 (0.49–1.38) 0.459 |
Antidiabetic Polypharmacy | Â | Â |
 All-cause ED visits | 1.47 (0.63–3.42) 0.376 | 1.76 (0.73–4.29) 0.210 |
 All-cause hospitalization | 1.04 (0.46–2.36) 0.934 | 1.30 (0.55–3.08) 0.551 |
 ED visits for pneumonia | 1.43 (0.33–6.20) 0.637 | 1.48 (0.32–6.84) 0.612 |
 Hospitalization for pneumonia | 1.39 (0.32–6.06) 0.659 | 1.42 (0.30–6.56) 0.650 |
 Mortality | 0.68 (0.28–1.65) 0.393 | 0.63 (0.24–1.64) 0.345 |